[1] KAJITANI T,KUNO K,HISHIDA Y,et al.Surgical treatment for hepatic hilar carcinoma[J].Shujutsu,1966,20:997-1002.
|
[2]ZHOU NX,HUANG ZQ,LIU YX,et al.National survey of extrahepatic biliary tract cancer:an analysis of 1098 cases[J].Chin JSurg,1990,28(9):516-521.(in Chinese)周宁新,黄志强,刘永雄,等.肝外胆道癌全国调查1098例分析[J].中华外科杂志,1990,28(9):516-521.
|
[3]LIANG TB,BAI XL.Multidisciplinary team diagnosis and treatment o hilar cholangiocarcinoma[J].Chin J Dig Surg,2015,14(4):268-274.(in Chinese)梁廷波,白雪莉.肝门部胆管癌多学科团队的诊断与治疗[J].中华消化外科杂志,2015,14(4):268-274.
|
[4]TAMOTO E,HIRANO S,TSUCHIKAWA T,et al.Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma[J].HPB(Oxford),2014,16(1):56-61.
|
[5] WU XS,DONG P,GU J,et al.Combined portal vein resection for hilar cholangiocarcinoma:a meta-analysis of comparative studies[J].J Gastrointest Surg,2013,17(6):1107-1115.
|
[6]EBATA T,NAGINO M,KAMIYA J,et al.Hepatectomy with portal vein resection for hilar cholangiocarcinoma:audit of 52 consecutive cases[J].Ann Surg,2003,238(5):720-727.
|
[7]LEE SG,LEE J,PARK KM,et al.One hundred and eleven liver resections for hilar bile duct cancer[J].J Hepatobiliary Pancreat Surg,2000,7(7):135-141.
|
[8]SHIMADA H,ENDO I,SUGITA M,et al.Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder[J].World J Surg,2003,27(10):1137-1142.
|
[9] Biliary Tract Group,Chinese Society of Surgery,Chinese Medical Association.Specialized Committee on Hepatobiliary Surgery of PLA.Guidelines for the diagnosis and treatment of hilar cholangiocarcinoma(2013 edition)[J].Chin J Surg,2013,51(10):865-871.(in Chinese)中华医学会外科学分会胆道外科学组,解放军全军肝胆外科专业委员会.肝门部胆管癌诊断和治疗指南(2013版)[J].中华外科杂志,2013,51(10):865-871.
|
[10]FAN Y,WU SD.An excerpt of hilar cholangiocarcinoma:expert consensus statement[J].J Clin Hepatol,2015,31(10):1588-1591.(in Chinese)范莹,吴硕东.《2014年美国肝胆胰学会共识声明:肝门部胆管癌管理》摘译[J].临床肝胆病杂志,2015,31(10):1588-1591.
|
[11]YAN FH,LI WX,LUO XF.Value of computed tomography in the diagnosis and resect-ability evaluation of hilar cholangiocarcinoma[J].Chin J Dig Surg,2014,13(6):441-446.(in Chinese)严福华,李卫侠,罗先富.CT检查在肝门部胆管癌诊断与可切除性评估中的价值[J].中华消化外科杂志,2014,13(6):441-446.
|
[12] MANTEL HT,WIGGERS JK,VERHEIJ J.Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma[J].Ann Surg Oncol,2015,22(Suppl 3):s1107-s1115.
|
[13]YANG SZ.The role of computer-aided operative planning system in the management of hilar cholangiocarcinoma:current status and future research directions[J].Chin J Pract Surg,2013,33(1):47-50.(in Chinese)杨世忠.计算机辅助手术规划系统在肝门部胆管癌治疗中应用现状及展望[J].中国实用外科杂志,2013,33(1):47-50.
|
[14]SU ZJ,DUAN P,LIU CH,et al.Application of three-dimensional visualization system in the treatment of hilar cholangiocarcinoma[J].Chin J Dig Surg,2013,12(3):213-216.(in Chinese)苏昭杰,段朋,刘昌华,等.三维可视化系统在肝门部胆管癌治疗中的应用[J].中华消化外科杂志,2013,12(3):213-216.
|